Zoster Vaccine, Recombinant Side Effects
Medically reviewed by Drugs.com. Last updated on Apr 22, 2024.
Applies to zoster vaccine, recombinant: intramuscular suspension.
Other side effects
Some side effects of zoster vaccine, recombinant may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
Less common side effects
- chills
- dizziness
- general feeling of discomfort or illness
- itching at the injection site
Serious side effects
Along with its needed effects, zoster vaccine, recombinant may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking zoster vaccine, recombinant:
Rare side effects
- ankle, knee, or great toe joint pain
- blindness
- blurred vision
- decreased vision
- eye pain
- fever greater than 39 degree Celsius
- joint stiffness or swelling
- lower back or side pain
- swollen, painful, or tender lymph glands in the neck, armpit, or groin
Incidence not known
For healthcare professionals
Applies to zoster vaccine, recombinant: intramuscular powder for injection.
Local adverse events
- Very common (10% or more): Local pain (88.4%), local redness (38.7%)
- Common (1% to 10%): Injection site pruritus[Ref]
Other
- Very common (10% or more): Fatigue (57%), shivering (35.8%), fever (27.8%)
- Common (1% to 10%): Malaise
- Uncommon (0.1% to 1%): Death[Ref]
Deaths were reported for 0.8% of patients in the treatment group during the first year after vaccination versus 0.9% of placebo patients. Causes of death were consistent with those generally reported in adult and elderly populations.[Ref]
Nervous system
- Very common (10% or more): Headache (50.6%)
- Common (1% to 10%): Dizziness[Ref]
Gastrointestinal
- Very common (10% or more): Gastrointestinal symptoms (24.3%)
- Common (1% to 10%): Nausea[Ref]
Metabolic
Ocular
- Rare (less than 0.1%): Optic ischemic neuropathy[Ref]
Hematologic
- Very rare (less than 0.01%): Lymphadenitis[Ref]
Musculoskeletal
References
1. (2017) "Product Information. Shingrix (zoster vaccine, inactivated)." GlaxoSmithKline
More about zoster vaccine, recombinant
- Check interactions
- Compare alternatives
- Reviews (630)
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- En español
Patient resources
- Zoster vaccine inactivated drug information
- Zoster vaccine recombinant, adjuvanted (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Zoster vaccine, recombinant side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.